In Vitro Diagnostics Market Forecast Through 2030 Featuring Industry Drivers And Opportunities

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The In Vitro Diagnostics Market Become By 2030 Compared To 2026?

The in vitro diagnostics market size has experienced significant growth in recent years. It is anticipated to increase from $136.55 billion in 2025 to $152.42 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. This historical expansion can be attributed to several factors, including the increased volume of diagnostic testing, a rise in infectious disease screening, the escalating prevalence of chronic conditions, enhancements in laboratory infrastructure, and broader access to healthcare services.

The in vitro diagnostics market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $241.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This growth during the forecast period is fueled by factors such as the greater adoption of decentralized diagnostics, escalating investments in molecular testing technologies, the broadening scope of personalized medicine diagnostics, a heightened demand for swift and precise testing, and the increasing incorporation of AI-driven diagnostic solutions. Key trends anticipated within this period encompass the wider embrace of point-of-care diagnostic devices, an escalating need for molecular and immunoassay testing, the expanding utilization of automated laboratory systems, the development of multiplex diagnostic platforms, and a reinforced emphasis on quick testing methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Are The Main Drivers Accelerating The Growth Of The In Vitro Diagnostics Market?

The rising incidence of cancer is projected to stimulate the expansion of the in vitro diagnostics market. Cancer itself is a broad category covering over 100 distinct diseases that can manifest in various parts of the body. This increase in cancer prevalence is attributed to shifts in lifestyle, such as greater tobacco use, unhealthy diets, lack of physical activity, and environmental pollution, which collectively heighten cancer risk among individuals. In vitro diagnostics (IVDs) are medical tests or devices that examine samples taken from the human body, supplying critical information for the screening, diagnosis, and treatment of cancer. For example, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, indicated that the United States is expected to see 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Thus, the growing prevalence of cancer is set to propel the in vitro diagnostics market forward.

What Segment Types Are Included In The In Vitro Diagnostics Market Analysis?

The in vitro diagnostics market covered in this report is segmented –

1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Which Trends Are Guiding The Development Of The In Vitro Diagnostics Market?

Key players in the in vitro diagnostics market are adopting advanced technologies like UIMG image technology and a 2D decoder chip to elevate the accuracy and efficiency of diagnostic tests, improve data analysis, streamline workflow processes, and ultimately achieve better patient outcomes. UIMG image technology is an advanced imaging method utilized in diagnostics to capture and analyze high-resolution images, thereby improving the visualization and interpretation of biological samples. For example, in November 2023, Newland, an EMEA, Netherlands-based technology company, launched its IVD (in vitro diagnostics) product line. This new IVD product line features five barcode scanners that are compact, rugged, and optimized for automated diagnostic processes. These scanners are intended to enhance the speed and accuracy of diagnostics, which is crucial given the increasing demand for efficient healthcare solutions.

Which Industry Players Are Present In The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Access The Complete In Vitro Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Commands The Largest Share Of The In Vitro Diagnostics Market?

North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a In Vitro Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2026, By The Business Research Company

In Vitro Diagnostics Ivd Quality Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

In Vitro Diagnostics Enzymes Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795